Accessibility Menu
 

Rexam Drops Despite Rise in Sales

Health-care performance lets down half-year results.

By Jon Wallis Updated Apr 7, 2017 at 2:21PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.